MR-guided radiotherapy for prostate cancer: an inevitable transition?
Based on available, preliminary evidence, MRgRT and adaptive SBRT are associated with a promising toxicity profiles. Nonetheless, further multicenter studies with extended follow-up are needed to validate outcomes and establish practice guidelines.
Authors
- Rafał Stando (ORCID: https://orcid.org/0000-0002-2543-8370)
- Grzegorz Chmielewski (ORCID: https://orcid.org/0000-0001-7835-523X)
Institutions
- College of the Holy Cross (US)
- Jan Kochanowski University (PL)
Publication Details
- Journal
- Current Opinion in Urology
- Published
- 2025-07-04
- DOI
- https://doi.org/10.1097/mou.0000000000001315
- Citations
- 1
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52